CXCL9 and neoplasm: To functionally assess potential systemic antitumor effects, mice bearing bilateral KPL-3M tumors were treated ipsilaterally with IT CXCL9/10 in combination with i.p. anti-PD-1, and bilateral tumor growth was monitored (Figure 7C).